Baird lowered the firm’s price target on Dentsply Sirona (XRAY) to $24 from $31. The firm said with implant and equipment pressures continuing, shares were likely going to be down today. Even with the shares at all-time low valuation, Baird sees too many company-specific challenges beyond just macro to recommend stepping in at current levels.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on XRAY:
- Dentsply Sirona Reports Mixed Q3 2024 Results
- Dentsply Sirona downgraded to Market Perform at Leerink on lack of visibility
- Dentsply Sirona downgraded to Market Perform from Outperform at Leerink
- DENTSPLY SIRONA Revises Outlook Amid Goodwill Impairments
- Dentsply Sirona reports Q3 adjusted EPS 50c, consensus 47c
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
